Trv Gp Iv
Latest statistics and disclosures from Trv Gp Iv's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TNGX, PLRX, FULC, and represent 100.00% of Trv Gp Iv's stock portfolio.
- Reduced shares in these 1 stock: TNGX (-$18M).
- Trv Gp Iv was a net seller of stock by $-18M.
- Trv Gp Iv has $162M in assets under management (AUM), dropping by -19.84%.
- Central Index Key (CIK): 0001688325
Tip: Access up to 7 years of quarterly data
Positions held by Trv Gp Iv consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Trv Gp Iv
Trv Gp Iv holds 3 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tango Therapeutics (TNGX) | 80.1 | $130M | -12% | 17M | 7.70 |
|
| Pliant Therapeutics (PLRX) | 14.8 | $24M | 2.1M | 11.21 |
|
|
| Fulcrum Therapeutics (FULC) | 5.2 | $8.4M | 2.3M | 3.57 |
|
Past Filings by Trv Gp Iv
SEC 13F filings are viewable for Trv Gp Iv going back to 2018
- Trv Gp Iv 2024 Q3 filed Nov. 6, 2024
- Trv Gp Iv 2024 Q2 filed Aug. 9, 2024
- Trv Gp Iv 2024 Q1 filed May 13, 2024
- Trv Gp Iv 2023 Q4 filed Feb. 14, 2024
- Trv Gp Iv 2023 Q3 filed Nov. 13, 2023
- Trv Gp Iv 2023 Q2 filed Aug. 10, 2023
- Trv Gp Iv 2023 Q1 filed May 12, 2023
- Trv Gp Iv 2022 Q4 filed Feb. 14, 2023
- Trv Gp Iv 2022 Q3 filed Nov. 3, 2022
- Trv Gp Iv 2022 Q2 filed Aug. 12, 2022
- Trv Gp Iv 2022 Q1 filed May 10, 2022
- Trv Gp Iv 2021 Q4 filed Feb. 14, 2022
- Trv Gp Iv 2021 Q3 filed Nov. 5, 2021
- Trv Gp Iv 2021 Q2 filed Aug. 11, 2021
- Trv Gp Iv 2021 Q1 filed May 12, 2021
- Trv Gp Iv 2020 Q4 filed Feb. 16, 2021